Klotho Neurosciences, Inc.
KLTO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $271 | $239 | $0 | $0 |
| G&A Expenses | $0 | $1,654 | $1,587 | $1,852 |
| SG&A Expenses | $1,582 | $1,654 | $1,587 | $1,852 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,853 | $1,893 | $1,587 | $1,852 |
| Operating Income | -$1,853 | -$1,893 | -$1,587 | -$1,852 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,042 | -$2,200 | -$647 | -$216 |
| Pre-Tax Income | -$2,896 | -$4,093 | -$2,234 | -$2,067 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,896 | -$4,093 | -$2,234 | -$2,067 |
| % Margin | – | – | – | – |
| EPS | -0.049 | -0.12 | -0.081 | -0.076 |
| % Growth | 59.4% | -47.8% | -6.4% | – |
| EPS Diluted | -0.049 | -0.12 | -0.081 | -0.076 |
| Weighted Avg Shares Out | 59,417 | 33,952 | 27,524 | 27,081 |
| Weighted Avg Shares Out Dil | 59,417 | 33,952 | 27,524 | 27,081 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,178 | $1,760 | $554 | $297 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1,718 | -$2,333 | -$1,680 | -$1,771 |
| % Margin | – | – | – | – |